Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 27.47
+0.28 (1.03%)
Feb 3, 2026, 3:00 PM CST
SHA:600993 Market Cap
SHA:600993 has a market cap or net worth of 11.72 billion as of February 3, 2026. Its market cap has increased by 6.38% in one year.
Market Cap
11.72B
Enterprise Value
9.31B
Revenue
3.77B
Ranking
n/a
PE Ratio
20.43
Stock Price
27.47
Market Cap Chart
Since June 22, 2004, SHA:600993's market cap has increased from 1.07B to 11.72B, an increase of 990.71%. That is a compound annual growth rate of 11.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 11.72B | -2.89% |
| Dec 31, 2025 | 12.07B | 7.24% |
| Dec 31, 2024 | 11.25B | 7.98% |
| Dec 29, 2023 | 10.42B | 6.99% |
| Dec 30, 2022 | 9.74B | -21.42% |
| Dec 31, 2021 | 12.40B | 42.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.67B |
| Guangdong Taienkang Pharmaceutical | 13.62B |
| Beijing Foyou Pharma CO.,LTD | 13.53B |
| Porton Pharma Solutions | 13.20B |
| Shenzhen Chipscreen Biosciences | 13.05B |
| Henan Lingrui Pharmaceutical | 12.37B |
| Zhejiang Hisun Pharmaceutical | 12.21B |
| Zhejiang CONBA Pharmaceutical | 11.43B |